Search for: "Price v. Holman"
Results 1 - 20
of 44
Sorted by Relevance
|
Sort by Date
14 May 2011, 6:39 am
Holman Jenkins, writing in today’s WSJ, appropriately mocks the notion driving the Rajaratnam prosecution that insider trading “law’s purpose is to protect the public from informed stock prices. [read post]
17 Feb 2013, 2:43 pm
On Tuesday, the Supreme Court hears argument in Bowman v. [read post]
5 Feb 2015, 4:21 pm
” The postscript to the reported judgment of Seagrove v. [read post]
10 Jun 2011, 1:40 pm
Holman, Do Reverse Payment Settlements Violate the Antitrust Laws? [read post]
24 Nov 2010, 12:37 am
Use of pipeline system (IP tango) EU: Notes from EU Parliament meeting on innovation+access for medical technologies (KEI) Netherlands: District Court of The Hague declares Dutch part of Bayer’s European patent covering anti-TNF alpha human monoclonal antibodies invalid (Kluwer Patent Blog) Southeast Asia: Generic drug market picks up steam in Southeast Asia, finds Front & Sullivan (GenericsWeb) Spain: Commercial Court No 5 of Barcelona: obtaining price for generic medicament an… [read post]
6 Apr 2016, 4:06 am
Supreme Court Association for Molecular Pathology v. [read post]
10 Oct 2008, 11:32 am
:Interpharma Pty Ltd v Commisioner of Patents (GenericsWeb) Gemzar (Gemcitabine) - US: Eli Lilly sues Teva for patent infringement and seek declaratory judgment (The IP Factor) (Law360) Glivec (Imatinib) - India: Supreme Court appoints Dr Chakraborty as technical member on IPAB panel hearing Glivec appeal (Spicy IP) Jeevani (Arogyapacha) - India: Recent developments in the Arogypacha case (Spicy IP) Miralax (Polyethylene glycol) - US: 'Advice of scientist' defense… [read post]
11 May 2011, 4:54 am
ARUP: Genetic testing patents found to be anticipated and in violation of Lilly written description requirement (Holman’s Biotech IP Blog) (Patent Docs) (Patently-O) US: FDA gets the ball rolling on biosimilar/interchangeable biological product user fee program; proposal gives a hat tip to PDUFA while acknowledging the nascent state of the industry (FDA Law Blog) (Patent Docs) Products Citalopram – UK Patents Court disapproving of EPO’s approach to assessment of novelty:… [read post]
9 May 2013, 9:22 am
One of the central policy issues injected into the current case of AMP v. [read post]
1 Apr 2010, 3:04 am
– TRIPS and price controls on patented pharmaceutical products (patentidbits) Assessing pharma patent strength (JIPLP) Canada: Health Canada releases final guidances on biosimilars (Pharmacapsules) US: District Court S D New York: ‘Isolated DNA’ patents fail to claim patentable subject matter: Association for Molecular Pathology and ACLU v. [read post]
24 Aug 2009, 7:01 am
(Tangible IP) Global IP law: Two recent publications ‘Global Challenge of Intellectual Property Rights’ by R Bird and S C Jain and ‘Global Intellectual Property Law’ by G Dutfield and U Suthersanen (IPKat) Global - Trade Marks / Brands What price brands on the balance sheet? [read post]
18 Nov 2009, 4:57 am
(Property, intangible) US: How do you solve a problem like Sidewiki (FDA Law Blog) US: Bio Podcast: The role of patents in a pathway for the approval of biosimilars (Holman's Biotech IP Blog) US: Lilly files principal brief for Ariad v Lilly rehearing en banc - Ariad Pharmaceuticals, Inc. v. [read post]
18 Nov 2009, 4:57 am
(Property, intangible) US: How do you solve a problem like Sidewiki (FDA Law Blog) US: Bio Podcast: The role of patents in a pathway for the approval of biosimilars (Holman's Biotech IP Blog) US: Lilly files principal brief for Ariad v Lilly rehearing en banc - Ariad Pharmaceuticals, Inc. v. [read post]
18 Nov 2009, 4:57 am
(Property, intangible) US: How do you solve a problem like Sidewiki (FDA Law Blog) US: Bio Podcast: The role of patents in a pathway for the approval of biosimilars (Holman's Biotech IP Blog) US: Lilly files principal brief for Ariad v Lilly rehearing en banc - Ariad Pharmaceuticals, Inc. v. [read post]
12 Apr 2011, 10:07 pm
Infringement proceedings by the European Commission against Italy (Kluwer Patent Blog) India approves free access to important portions of the Traditional Knowledge Digital Library (TK Community) (Spicy IP) USPTO proposes changes to PTA and PTE provisions (Patent Docs) US: FDA issues warning letter for failure to submit animal study reports in an IDE (FDA Law Blog) US: AMP v USPTO – oral argument at the Federal Circuit (Patent Docs) US: A historical perspective on the gene patent… [read post]
15 Jun 2011, 4:56 am
General Big Pharma accepts differential pricing – FINALLY! [read post]
29 Dec 2010, 2:57 am
Mayo Collaborative Services (Patently-O) (Filewrapper) (Patents4Life) (Patent Docs) (Inventive Step) US: Lawsuit alleging infringement of canine genotyping patent raise interesting patent eligibility issues (Holman’s Biotech IP Blog) US: Will Bessie, Porky, Puss and Poly get their meds? [read post]
11 Jan 2011, 11:56 pm
HOLMAN v SUFFOLK COUNTY COUNCIL, 15/9/2010 18. [read post]
7 Apr 2010, 4:30 am
– Myriad stock prices: Association of Molecular Pathology v USPTO (Innovationpartners) US: Federal judge in Myriad patent case says invalidation of gene patents does not violate TRIPS: Association of Molecular Pathology v USPTO (KEI) US: ACLU gene patent decision from an investor’s perspective: A black eye for the US patent system: Association of Molecular Pathology v USPTO (Holman's Biotech IP Blog) US: Association of Molecular Pathology… [read post]
